Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

Pfizer PFE will report its third-quarter 2025 earnings on Nov. 4, before market open. The Zacks Consensus Estimate for sales ...

The move, announced Thursday, escalates the competition between the two pharmaceutical giants for a critical advantage in the ...

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $20.0 to $30.0 for Pfizer during the past quarter. Looking at the volume ...

To get a sense of who is truly in control of Pfizer Inc. (NYSE:PFE), it is important to understand the ownership structure of ...

Pfizer (NYSE: PFE) continues to lag the market. Over the past few years, the company has generally reported declining revenue and profits, resulting in a substantial decline in market value. The ...

Pfizer will reduce prices on drugs sold to Medicare patients. The Trump administration has made cutting prescription drug prices a priority. Ultimately, the administration aims to have Americans ...

Investors in Pfizer Inc (Symbol: PFE) saw new options begin trading today, for the January 2028 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the ...

Pfizer faces a significant patent cliff, pricing reforms, and limited financial flexibility from high debt, all threatening future earnings growth. Weak share price momentum and sector ...

Pfizer stock offers a yield above 6% at recent prices. MPLX LP is a pipeline operator that offers a yield above 7% at the moment. Pfizer and MPLX LP could continue raising their dividend payouts for ...